Lexington, KY, United States of America

Jacob Concolino

This inventor holds 1 USPTO granted patent. Top assignee: University of Kentucky Research Foundation. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacob Concolino: Innovator in Antiviral Technology

Introduction

Jacob Concolino is an inventive mind based in Lexington, KY (US). He has made significant contributions to the field of antiviral technology, particularly through his innovative designs in personal protective equipment.

Latest Patents

Concolino holds a patent for an antiviral mask and antiviral filter made from a breathable microporous polymeric membrane. This advanced mask features a thin, breathable membrane that includes a plurality of pores functionalized with a proteolytic enzyme, an antibody, or a combination thereof. Additionally, the antiviral mask may incorporate a coating of graphene oxide, lignin sulfonate, or a combination thereof, along with a fluorescent virus tagging agent. This patent showcases his commitment to enhancing public health through innovative solutions.

Career Highlights

Jacob Concolino is affiliated with the University of Kentucky Research Foundation, where he continues to develop groundbreaking technologies. His work focuses on creating effective solutions to combat viral infections, demonstrating his dedication to improving health outcomes.

Collaborations

Concolino collaborates with esteemed colleagues such as Dibakar Bhattacharyya and J Todd Hastings. Their combined expertise fosters an environment of innovation and research excellence.

Conclusion

Jacob Concolino is a notable inventor whose work in antiviral technology is paving the way for safer and more effective protective measures. His contributions are vital in the ongoing fight against viral infections, and his innovative spirit continues to inspire advancements in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…